You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. N/A

    SBC: INVOTEK, INC.            Topic: N/A

    N/A

    STTR Phase II 2000 Department of Health and Human ServicesNational Institutes of Health
  2. New Rare-Earth-Doped Glass Fiber Lasers and Amplifiers for 1.54 um Communications

    SBC: KIGRE, INC.            Topic: N/A

    Kigre's Phase I fiber amplifier development effort demonstrated 10dB of internal gain at 1.54um from 2.2 cm long section of MM-2 erbium ytterbium phosphate fiber amplifier pumped at 980nm. 26dB of gain was also produced from a 8.8com long section of thissame fiber pumped at 1480nm. Mode field image testing of a fiber show this MM-2 fiber to be perfect 1.54um single mode containment match to stan ...

    STTR Phase II 2001 Department of DefenseMissile Defense Agency
  3. FISO Digitizer for Flash Capture A/D Conversion

    SBC: DAKOTA TECHNOLOGIES, INC.            Topic: ST021006

    Numerous DoD systems critically rely on accurately capturing nanosecond transient signals. For sampling rates of 1 GS/s or greater, conventional flash A/D converters (ADCs) suffer from limited resolution (~8 bits), high power (ca. 5 watts/channel), and high cost. Extensive modeling conducted by Dakota Technologies, Inc. (DTI) and Lawrence Berkeley National Laboratory (LBNL) during Phase I proved t ...

    STTR Phase II 2004 Department of DefenseDefense Advanced Research Projects Agency
  4. New Broad Band Rare-Earth-Doped Glasses For Optical Fiber Communications

    SBC: KIGRE, INC.            Topic: BMDO01T001

    Kigre is developing new scalable high gain broad band rare earth doped laser oscillator/amplifier glass materials & diode pump architectures in support of high energy and high power laser applications. What's new, exciting and different about Kigre's laser glass materials and constructs is the ability to efficiently store and extract 1000-10,000x more laser power from ultra-short gain lengths and ...

    STTR Phase II 2004 Department of DefenseDefense Advanced Research Projects Agency
  5. New Rare-Earth-Doped Glasses for Planar Waveguide Lasers & Amplifiers

    SBC: KIGRE, INC.            Topic: MDA96T002

    This STTR Phase II project continues the development of a new glass (designated MM-i) for ion-exchange glass waveguides and amplifiers used in l.55 um optical communication systems. There is excellent commercial potential for these glass materials and the waveguide lasers (lossless splitters) and optical amplifiers that may be fabricated from them. To date, development efforts in the communication ...

    STTR Phase II 2005 Department of DefenseMissile Defense Agency
  6. Magnetohydrodynamic-based Laboratories on a Chip

    SBC: VEGRANDIS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): In this Phase II project, Vegrandis, LLC proposes to develop a magnetohydrodynamic (MHD) microfluidic based "sample-in, answer-out" bioassay chip for diagnosis of ovarian cancer. The proposed bioassay chip will use MHD microfluidics to pump the sample and reagents necessary to perform the assay and will have integrated micro-electrochemical detection of a panel ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  7. Development of Plant Derived Antibodies for Drugs Abuse

    SBC: INTERVEXION THERAPEUTICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this combination Phase I / Phase II STTR project is to test the hypothesis that anti-drug monoclonal antibodies are a safe and effective therapy for the medical problems associated with phencyclidine (PCP) abuse. There are currently no specific medications for treating the medical problems caused by acute or chronic PCP abuse. Thus, long-lasting m ...

    STTR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  8. Novel accelerated in vitro breeding for phytoremediation

    SBC: SOUTHERN SUN BIOSYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term goal of the collaboration between the USC and Southern Sun BioSystems is to create a plant breeding and remediation technology-development center which would supply hardware, protocols for breeding-selection and mass production of elite plants for nurseries and remediation businesses, with licensing and tracking mechanisms for protecting intellect ...

    STTR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  9. Point Source Ozonation to Minimize Antibiotic Resistance

    SBC: Biodetection Instruments, Inc            Topic: N/A

    DESCRIPTION (provided by applicant): In this Phase II project, BlueInGreen, LLC will build a hypersaturated dissolved ozone (HYDOZTM) unit to deploy in a large pilot-scale study at Springdale Wastewater Treatment Facility (SWWTF) in Springdale, Arkansas. F urthermore, BlueInGreen will collaborate with the University of Arkansas to measure the ability of HYDOZ ozonation to remove refractory microbe ...

    STTR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  10. Restoration of Skin Structure and Function Post-Wounding

    SBC: FirstString Research, Inc            Topic: N/A

    DESCRIPTION (provided by applicant): The wound repair process in skin is initiated immediately after an injury and induces a cascade of events including inflammation, proliferation, and scar differentiation. The adverse changes in skin structure and function resulting from scar tissue affects over 35 million US citizens a year resulting in costs of more than 7 billion dollars). The founders of Fir ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government